Early Detection and Curative Treatment of Early-Stage Hepatocellular Carcinoma Masatoshi Kudo Clinical Gastroenterology and Hepatology Volume 3, Pages S144-S148 (October 2005) DOI: 10.1016/S1542-3565(05)00712-3 Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 1 Cumulative survival rate after curative RFA. Clinical Gastroenterology and Hepatology 2005 3, S144-S148DOI: (10.1016/S1542-3565(05)00712-3) Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 2 Recurrence rates after curative RFA. Clinical Gastroenterology and Hepatology 2005 3, S144-S148DOI: (10.1016/S1542-3565(05)00712-3) Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 3 Cumulative first recurrence rates after RFA. IFN, interferon. Clinical Gastroenterology and Hepatology 2005 3, S144-S148DOI: (10.1016/S1542-3565(05)00712-3) Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 4 Disease-controlled survival rates at 5 years. IFN, interferon. Clinical Gastroenterology and Hepatology 2005 3, S144-S148DOI: (10.1016/S1542-3565(05)00712-3) Copyright © 2005 American Gastroenterological Association Terms and Conditions